_id: aca1aed0-1a04-11ea-902e-ed5138904e22
name: BardacGAl
email: cb8594504a7e4a6c723d8d3c5c096c20
message: "investigational oral p38 MAP kinase inhibitor, for the treatment of rheumatoid arthritis. A copy  John Alam, M.D., Executive Vice President, Medicines Development and Chief Medical Officer  (DAS28; p=0.02) and morning stiffness (p=0.03).  gastroenteritis, nausea/vomiting, rash, and renal impairment (increased serum  \r\n<a href=http://nauseainthemorning.ml/treatment-options-for-osteoarthritis-in-the-mild-nausea-in-the-morning-not>mild nausea in the morning not pregnant</a>"
date: '2019-12-08T21:49:57.236Z'
